Thakral Services India Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Thakral Services (India) Ltd is ₹ 13 as of 21 Oct 15:30 . The P/E Ratio of Thakral Services (India) Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Thakral Services (India) Ltd changed from ₹ 8.23 crore on March 2021 to ₹ 18.11 crore on March 2026 . This represents a CAGR of 14.05% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Thakral Services (India) Ltd for the Jun '26 is ₹ 0.29 crore as compare to the Mar '26 revenue of ₹ 0.41 crore. This represent the decline of -29.27% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Thakral Services (India) Ltd for the Jun '26 is ₹ -0.01 crore as compare to the Mar '26 ebitda of ₹ 0.12 crore. This represent the decline of -108% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Thakral Services (India) Ltd changed from ₹ -0.1 crore to ₹ -0.01 crore over 9 quarters. This represents a CAGR of -64.06% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Thakral Services (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Thakral Services (India) Ltd

Thakral Services (India) Limited was incorporated on January 25, 1983 as Private Limited Company with the name Parvidhgaar Leasing Pvt.
Ltd. On November 18, 1985, the Company was converted into a Limited Company and renamed as Parvidhgaar Leasing & Finance Limited.
The name of the Company was further changed to Primeast Investments Limited on November 16, 1994.
Subsequently, the name of the Company was changed from Primeast Investments Limited to Thakral Services (India) Limited on February 06, 2007.
The Company is mainly engaged in the business of Electronic Security which comprises of CCTV, Access control, Fire Detection, Alarms, Intrusion Alarms and Solar Power Solutions. During the year 2011-12, the company extended its operations in the field of Photo Voltaic Modules and presently engaged in CCTV Sales.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Thakral Services (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Thakral Services (India) Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Thakral Services (India) Ltd is 15 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Thakral Services (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Thakral Services (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Thakral Services (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Thakral Services (India) Ltd stock price is INR ₹13.0. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Thakral Services (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Thakral Services (India) Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.